18.70
29.77%
4.29
After Hours:
18.70
Embecta Corp stock is traded at $18.70, with a volume of 1.87M.
It is up +29.77% in the last 24 hours and up +34.53% over the past month.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
See More
Previous Close:
$14.41
Open:
$17.18
24h Volume:
1.87M
Relative Volume:
5.07
Market Cap:
$1.06B
Revenue:
$1.12B
Net Income/Loss:
$55.30M
P/E Ratio:
23.09
EPS:
0.81
Net Cash Flow:
$-30.30M
1W Performance:
+38.72%
1M Performance:
+34.53%
6M Performance:
+42.42%
1Y Performance:
+6.92%
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
18.70 | 1.06B | 1.12B | 55.30M | -30.30M | 0.81 |
ISRG
Intuitive Surgical Inc
|
542.10 | 192.91B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
224.25 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
87.24 | 43.15B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.99 | 36.48B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
319.35 | 23.17B | 2.88B | 499.60M | 321.60M | 7.41 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Sep-08-22 | Initiated | BTIG Research | Neutral |
Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
Jun-21-22 | Initiated | BofA Securities | Underperform |
Embecta Corp Stock (EMBC) Latest News
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps - AOL
Embecta Pumps the Brakes on Insulin Patch Pump Program - MD+DI
Embecta to shutter newly-cleared insulin patch pump program amid restructuring - Fierce Biotech
Embecta discontinues insulin patch pump program, plans restructuring - Mass Device
Embecta to Cease Insulin Patch Pump Program, Begins Restructuring - MPO-mag
Embecta discontinues insulin patch pump development - MedTech Dive
Embecta stock hits 52-week high at $19.79 amid market fluctuations - Investing.com India
Embecta Shares Surge on Solid Guidance, Restructuring Plan - MarketWatch
Embecta Corp. Announces Quarterly Cash Dividend, Payable December 18, 2024 - Marketscreener.com
Embecta earnings beat by $0.09, revenue topped estimates - Investing.com
Embecta (NASDAQ:EMBC) Issues FY 2025 Earnings Guidance - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Announces $0.15 Quarterly Dividend - MarketBeat
Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
Embecta to discontinue insulin patch pump program, initiates restructuring plan - TipRanks
Embecta Unveils $65M Cost-Saving Plan, Exits Insulin Pump Program Amid Mixed Q4 | EMBC Stock News - StockTitan
Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full - GlobeNewswire
Embecta Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
embecta Announces Quarterly Cash Dividend - The Manila Times
Embecta Announces Quarterly Cash Dividend - Marketscreener.com
Uncovering Potential: Embecta's Earnings Preview - Benzinga
Jennison Associates LLC Invests $594,000 in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Segall Bryant & Hamill LLC Buys New Shares in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
(EMBC) Long Term Investment Analysis - Stock Traders Daily
Embecta (EMBC) to Release Quarterly Earnings on Tuesday - MarketBeat
UPDATEembecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Embecta (EMBC) to Share Q4 Earnings, 2025 Outlook in November 26 Call | EMBC Stock News - StockTitan
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Embecta (EMBC) to Share Q4 Earnings, 2025 Guidance in Upcoming Call | EMBC Stock News - StockTitan
New York State Teachers Retirement System Sells 1,100 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
embecta Corp. Rings the Closing Bell - Nasdaq
Creative Planning Sells 5,162 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell - GlobeNewswire
Embecta Marks 100 Years of Diabetes Care Innovation at Nasdaq Closing Bell Ceremony | EMBC Stock News - StockTitan
River Road Asset Management LLC Trims Stock Holdings in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Raymond James & Associates Sells 3,496 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Allspring Global Investments Holdings LLC Sells 6,467 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta Corp. (NASDAQ:EMBC) Sees Significant Increase in Short Interest - MarketBeat
Celebrating embecta’s 100-year Legacy as a Global Leader in Diabetes Care - The Malaysian Reserve
Celebrating embecta's 100-year Legacy as a Global Leader in Diabetes Care - Canada NewsWire
(EMBC) Trading Advice - Stock Traders Daily
SG Americas Securities LLC Takes $207,000 Position in Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta Corp (EMBC) Shares Down 3.42% on Sep 18 - GuruFocus.com
Embecta (NASDAQ:EMBC) Trading 3.2% HigherHere's What Happened - MarketBeat
Navigating the challenges and opportunities of a 100-year-old startup - Fast Company
Long Term Trading Analysis for (EMBC) - Stock Traders Daily
Taking on analysts’ expectations and winning: Embecta Corp (EMBC) - SETE News
Embecta Corp. (NASDAQ:EMBC) Short Interest Down 17.9% in September - MarketBeat
How To Trade (EMBC) - Stock Traders Daily
Embecta (NASDAQ:EMBC) Trading Down 4.2%What's Next? - MarketBeat
Dimensional Fund Advisors LP Has $5.36 Million Holdings in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Point72 Asset Management L.P. Has $142,000 Stock Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):